cgs 26303 has been researched along with Ischemic Attack, Transient in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arthur, A; Caner, HH; Jeng, AY; Kassell, NF; Kwan, AL; Lappe, RW; Lee, KS | 1 |
| Bavbek, M; Jeng, AY; Kassell, NF; Kwan, AL; Lappe, RW; Lee, KS; Maniara, W; Toyoda, T | 1 |
| Bavbek, M; Jeng, AY; Kassell, NF; Kwan, AL; Lee, KS; Toyoda, T | 1 |
3 other study(ies) available for cgs 26303 and Ischemic Attack, Transient
| Article | Year |
|---|---|
Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage.
Topics: Animals; Disease Models, Animal; Endothelin-1; Endothelins; Ischemic Attack, Transient; Organophosphonates; Protease Inhibitors; Protein Precursors; Rabbits; Subarachnoid Hemorrhage; Tetrazoles; Time Factors | 1996 |
Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhage.
Topics: Animals; Disease Models, Animal; Ischemic Attack, Transient; Male; Organophosphonates; Protease Inhibitors; Rabbits; Subarachnoid Hemorrhage; Tetrazoles | 1997 |
Attenuation of experimental subarachnoid hemorrhage-induced cerebral vasospasm by CGS 26303, an endothelin-converting enzyme inhibitor.
Topics: Animals; Aspartic Acid Endopeptidases; Dose-Response Relationship, Drug; Endothelin-Converting Enzymes; Ischemic Attack, Transient; Metalloendopeptidases; Organophosphonates; Protease Inhibitors; Rabbits; Subarachnoid Hemorrhage; Tetrazoles | 1998 |